Apoptosis of skeletal muscles during development and disease

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 12, 1999, Pages 1373-1390

  Sandri, Marco ^a   Carraro, Ugo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Apoptosis; Bax; Bcl 2; Caspase; Exercise induced muscle damage; Fas; FasL; Muscular dystrophy; Programmed cell death; Skeletal muscle; Ubiquitin

Indexed keywords

CASPASE; DNA FRAGMENT; FAS ANTIGEN; LIPOCORTIN 5; PROTEIN BCL 2;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE FIBRIL; MUSCULAR DYSTROPHY; MYOBLAST; MYOPATHY; NONHUMAN; REVIEW; SKELETAL MUSCLE;

ANIMALIA;

EID: 0032701375     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00063-1     Document Type: Article

References (95)

1. Lockshin R.A., Williams C.M. Programmed cell death. I. Cytology of the degeneration of the intersegmental muscles of the Pernyi silkmoth. J. Insect Physiol. 11:1965;123-133.
2. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.
3. Schwartz L.M., Osborne B.A. Programmed cell death and killer genes. Immunol. Today. 14:1993;582-590.
4. Kerr J.F. Shrinkage necrosis: a distinct mode of cellular death. J. Pathol. 105:1971;13-20.
5. Kerr J.F., Wyllie A.H., Curri A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
6. Wyllie A.H. Glucorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
7. Lockshin R.A., Zakeri Z. Apoptosis in the cytoplasm. Basic Appl. Myol. 6:1996;209-214.
8. Richter C., Schweizer M., Cossarizza A., Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett. 378:1996;107-110.
9. Vercammen B.D., Brouckaert G., Denecker G., Van de Craen M., Declercq W., Fiers W., Vandenabeele P. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188:1998;919-930.
10. Laster S.M., Wood J.G., Gooding L.R. Tumor Necrosis Factor can induce both apoptotic and forms of cell lysis. J. Immunol. 141:1988;2629-2635.
11. Haustetter A., Izumo S. Apoptosis basic mechanism and implication for cardiovascular disease. Circ. Res. 82:1998;1111-1129.
12. Smith J., Fowkes G., Schofield P.N. Programmed cell death in dystrophic (mdx) muscle is inhibited by IGF-II. Cell Death Differ. 2:1995;243-251.
13. Stewart C.E.H., Rotwein P. Insulin-like Growth Factor II is an autocrine factor for differentiating myoblasts. J. Biol. Chem. 271:1996;11,330-11,338.
14. Wang J., Walsh K. Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation. Science. 273:1996;359-361.
15. Mampuru L.J., Chen S-J., Kalenik J.L., Bradley M.E., Lee T-C. Analysis of events associated with serum deprivation-induced apoptosis in C3H/Sol8 muscle satellite cells. Exp. Cell Res. 226:1996;372-380.
16. Fimia G.M., Gottifredi V., Passananti C., Bellei B., Ricciardi R.M., Tafuri A., Amati P., Maione R. The activity of differentiation factors induces apoptosis in polyomavirus large T-expressing myoblasts. Mol. Biol. Cell. 9:1998;1449-1463.
17. Fimia G.M., Gottifredi V., Passananti C., Maione R. Double-stranded internucleosomal cleavage of apoptotic DNA is dependent on the degree of differentiation in muscle cells. J. Biol. Chem. 271:1996;15,575-15,579.
18. Sandri M., Podhorska-Okolow M., Geromel V., Rizzi C., Arslan P., Franceschi C., Carraro U. Exercise induces myonuclear ubiquitination and apoptosis in dystrophin deficient muscle of mice. J. Neuropath. Exp. Neurol. 56:1997;45-57.
19. Smith J. Muscle growth factors, ubiquitin and apoptosis in dystrophic muscle: apoptosis declines with age in the mdx mouse. Basic Appl. Myol. 6:1996;279-284.
20. Kang S.M., Hofman A., Le D., Springer M.L., Stck P.G., Blau H. Immune response and myoblasts that express Fas ligand. Science. 278:1997;1322-1324.
21. Giurisato E., Sandri M., Sandri C., Zuin R., Ancona G.G., Cantini M. Proliferating myoblast transfected with FasL cDNA can escape from apoptosis. Basic Appl. Myol. 8:1998;447-451.
22. Dominov J.A., Dunn J.J., Miller J.B. Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells. J. Cell Biol. 142:1998;537-544.
23. Kumagai T., Miki T., Kikuchi M., Fukuda T., Miyasaka N., Kamiyama R., Hirosawa S. The proto-oncogene Bcl6 inhibits apoptotic cell deayh in differentiation-induced mouse myogenic cells. Oncogene. 18:1998;467-475.
24. Stangel M., Zettl U.K., Mix E., Zielasek J., Toyka K.V., Hartung H.P., Gold R. H2O2 and Nitric Oxyde-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblast. J. Neuropathol. Exp. Neurol. 55:1996;36-43.
25. Ruffini S., Rainaldi G., Abbrachio M.P., Fiorentini C., Capri M., Franceschi C., Melorni W. Actin cytoskeleton as a target for 2-chloro adenosine: Evidence for induction of apoptosis in C2C12 myoblast cell culture. Biochem. Biophysic Res. Commun. 238:1997;361-366.
26. S. Soddu, S. Coen, M.A. Cerone, A. Porrello, G. Mazzaro, Wild-type p53 protein is involved in skeletal muscle differentiation: dissection of molecular mechanism, Abstract Book VII Telethon Convention, 1998, p. 163.
27. Sandri M., Massimino M.L., Cantini M., Giurisato E., Sandri C., Arslan P., Carraro U. Dystrophin deficient myotubes undergo apoptosis in mouse primary muscle cell culture after DNA damage. Neurosci. Lett. 252:1998;123-126.
28. Soddu S., Blandino G., Scardigli R., Coen S., Marchetti A., Rizzo M.G., Bossi G., Cimino L., Crescenzi M., Sacchi A. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol. 134:1996;193-204.
29. Nakagawa H., Mutoh T., Kumano T., Kuriyama M. HMG-CoA reductase inhibitor-induced L6 myoblast cell death: involvement of the phosphatidylinositol 3-kinase pathway. FEBS Letters. 438:1998;289-292.
30. Bhagwati S., Leung B., Shafiq S.A., Ghatpande A. Myotonic dystrophy: decreased levels of myotonin protein kinase (Mt-PK) leads to apoptosis in muscle cells. Exp. Neurol. 146:1997;277-281.
31. Abu-Shakra S., Alhalabi M.S., Nachtman F.C., Schemidt R.A., Brusilow W.S.A. Anabolic steroids induce injury and apoptosis of differentiated skeletal muscle. J. Neurosci. Res. 47:1997;186-197.
32. Maglara A., Jackson M.J., McArdle A. Programmed cell death in skeletal muscle. Biochem. Soc. T. 26:1998;S259.
33. Endo T., Nadal-Ginard B. Reversal of myogenic terminal differentiation by SV40 large T antigen results in mitosis and apoptosis. J. Cell Sci. 111:1998;1081-1093.
34. Wang J., Guo K., Willis K.N., Walsh K. Rb function to inhibit apoptosis during myocyte cell death. Cancer Res. 57:1997;351-354.
35. Vachon P.H., Loechel F.L., Xu H., Wewer U.M., Engvall E. Merosin and laminin in myogenesis; specific requiremnt for merosin in myotube stability and survival. J. Cell Biol. 134:1996;1483-1497.
36. Nishikawa A., Hayashi H. Spatial, temporal and hormonal regulation of programmed muscle cell death during metamorphosis of the frog Xenopus laevis. Differentiation. 59:1995;207-214.
37. McClearn D., Medville R., Noden D. Muscle cell death during the development of head and neck muscles in the chick embryo. Dev. Dynam. 202:1995;365-377.
38. Kaminska A.M., Fidzianska A. Experimental induction of apoptosis and necrosis in neonatal rat skeletal muscle. Basic Appl. Myol. 6:1996;251-256.
39. Fidzianska A. Apoptosis in human embryonic and diseased skeletal muscle. Basic Appl. Myol. 6:1996;261-264.
40. Webb J.N. The development of human skeletal muscle with particular reference to muscle cell death. J. Pathol. 123:1972;175-180.
41. Fidzianska A., Goebel H.H. Human ontogenesis III. Cell death in fetal muscle. Acta Neuropathol. (Berlin). 81:1991;572-579.
42. Thomazy V.A., Davies J.A. Expression of tissue transglutaminase in the developing chicken limb is associated both with apoptosis and endochondral ossification. Cell Death Differ. 6:1999;146-154.
43. KIP2 control muscle differentiation at the myogenin step. Genes & Dev. 13:1998;213-224.
44. Ohlendieck K. Structure and function of the dystrophin-glycoprotein complex. Basic Appl. Myol. 4:1994;227-237.
45. Ohlendieck K. Fate of dystrophin-associated glycoproteins in dystrophic muscle fibres. Basic Appl. Myol. 6:1996;265-272.
46. McArdle A., Edwards R.H.T., Jackson M.J. How does dystrophin deficiency lead to muscle degeneration? Evidence from the mdx mouse. Neuromuscular Disorders. 5:1995;445-456.
47. McArdle A., Catapano M., Davis A., Milburn S., Edwards R.H.T., Jackson M.J. Thyroid hormone mediates the acute phase of muscle degeneration in the dystrophin-deficient mdx mouse. J. Physiol. 489:1995;149P.
48. Coulton G.R., Rogers B., Strutt P., Skinner M.J., Watt D.J. In situ localisation of single stranded DNA breaks in nuclei of a subpopulation of cells within regenerating skeletal muscle of the dystrophic mdx mouse. J. Cell Sci. 102:1992;653-657.
49. Sandri M., Carraro U., Podhorska-Okolow M., Rizzi C., Arslan P., Monti D., Franceschi C. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Letters. 373:1995;291-295.
50. Tidball J.G., Albrecht D.E., Lokensgard B.E., Spencer M.J. Apoptosis precedes necrosis of dystrophin-deficient muscle. J. Cell Sci. 108:1995;2197-2204.
51. Matsuda R., Nishikawa A., Tanaka H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evens Blue: evidence of apoptosis in dystrophin deficient muscle. J. Biochem (Tokio). 118:1995;959-964.
52. Veal E.A., Jackson M.J. Expression of programmed cell death-related genes in dystrophic mdx and control mouse muscle. Basic Appl. Myol. 6:1996;312.
53. Veal E.A., Jackson M.J. Ubiquitin, c-myc, bcl-2, bax and other relevant genes in normal and mdx mouse muscle at various stages of the life cycle. Basic Appl. Myol. 6:1996;311.
54. Spencer M.J., Walsh C.M., Dorshkind K.A., Rodriguez E.M., Tidball J.G. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J. Clin. Inv. 99:1997;2745-2751.
55. Miyagoe Y., Hanaoka K., Nonaka I., Hayasaka M., Nabeshima Y., Arahata K., Nabeshima Y., Takeda S. Laminin α2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin2)-deficient congenital muscular dystrophy. FEBS Lett. 415:1997;33-39.
56. Vachon P.H., Lu H., Liu L., Loechel F., Hayashi Y., Arahata K., Reed J.C., Wewer U.M., Engvall E. Integrins (α7β1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Inv. 100:1997;1870-1881.
57. Hack A.A., Ly C.T., Jiang F., Clendenin C.J., Sigrist K.S., Wollmann R.L., McNally E.M. γ-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J. Cell Biol. 142:1998;1279-1287.
58. Taverna D., Disatnik M.H., Rayburn H., Bronson R.T., Yang J., Rando T.A., Hynes R.O. Dystrophic muscle in mice chimeric for expression of α5 integrin. J. Cell Biol. 143:1998;849-859.
59. Rosenblatt J.D., Yong D., Parry D.J. Satellite cell activity is required for hypertrophy of overloaded adult rat muscle. Muscle Nerve. 17:1994;608-613.
60. Darr K.C., Schultz E. Exercise-induced satellite cell activation in growing and mature skeletal muscle. J. Appl. Physiol. 63:1987;1816-1821.
61. Hikida R.S., Van Nostran S., Murray J.D., Staron R.S., Gordon S.E., Kraemer W.J. Myonuclear loss in atrophied soleus muscle fibers. Anat. Rec. 247:1997;350-354.
62. Allen D.L., Linderman J.K., Roy R.R., Bigbee A.J., Grindeland R.E., Mukku V., Edgerton V.R. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am. J. Physiol. 273:1997;C579-C587.
63. Tews D.S., Goebel H.H., Schneider I., Gunkel A., Stennert E., Neiss W.F. DNA-fragmentation and expression of apoptosis-related proteins in experimentally denervated and reinnervated rat facial muscle. Neuropathol. Appl. Neurobiol. 23:1997;141-149.
64. Tews D.S., Goebel H.H., Schneider I., Gunkel A., Stennert E., Neiss W.F. Expression of different isoforms of nitric oxide synthase in experimentally denervated and reinnervated skeletal muscle. J. Neuropath Exp. Neurol. 56:1997;1283-1289.
65. Vescovo G., Zennaro R., Sandri M., Carraro U., Leprotti C., Ceconi C., Ambrosio G.B., Dalla Libera L. Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J. Mol. Cell Cardiol. 30:1998;2449-2459.
66. Carraro U., Franceschi C. Apoptosis of skeletal and cardiac muscles and physical exercise. Aging-Cl. Exp. Res. 9:1997;19-34.
67. Bar D.P.R., Rodenburg A.J.B., Koot R.W., Amelik H.G.J. Exercise-induced muscle damage: recent developments. Basic Appl. Myol. 4:1994;5-16.
68. Sandri M., Podhorska-Okolow M., Geromel V., Rizzi C., Arslan P., Franceschi C., Carraro U. Sudden spontaneous exercise increases myonuclear ubiquitination and apoptosis of dystrophin deficient muscle. Basic Appl. Myol. 6:1996;285-289.
69. Thompson H.S., Scordilis S.P. Ubiquitin changes in human biceps muscle following exercise-induced damage. Biochem. Biophys. Res. Commun. 204:1994;1193-1198.
70. Haas A.L., Bright P.M., Jackson V.E. Functional diversity among putative E2 isozymes in the mechanism of ubiquitin-histone ligation. J. Biol. Chem. 263:1988;13,268-13,275.
71. Biral D., Sandri M., Jakubiec-Puka A. The fate of dystrophin and some signs of apoptosis in the skeletal muscle work-overloaded in extension. Basic Appl. Myol. 8:1998;205-210.
72. Podhorska-Okolow M., Sandri M., Zampieri S., Brun B., Rossini K., Carraro U. Apoptosis of myofibers and satellite cells: exercise-induced damage in skeletal muscle of mouse. Neuropathol. Appl. Neurobiol. 24:1998;518-531.
73. Behrens L., Bender A., Johnson M.A., Hohfeld R. Cytotoxic mechanism in inflammatory myopathies Co-expression of Fas and protective bcl-2 in muscle fibres and inflammatory cells. Brain. 120:1997;929-938.
74. Inukai A., Kobayashi Y., Ito K., Doyu M., Takano A., Honda H., Sobue G. Expression of Fas antigen is not associated with apoptosis in human myopathies. Muscle Nerve. 20:1997;702-709.
75. Migheli A., Mongini T., Doriguzzi C., Chiado-Piat L., Piva R., Ugo I., Palmucci L. Muscle apoptosis in humans occurs in normal and denervated muscle, but not in myotonic dystrophy, dystrophinopathies or inflammatory disease. Neurogenet. 1:1997;81-87.
76. Tews D.S., Goebel H.H. DNA fragmentation and expression of apoptosis-related proteins in muscular dystrophies. Neuropathol. Appl. Neurobiol. 23:1997;331-338.
77. Sandri M., Minetti C., Pedemonte M., Carraro U. Apoptotic myonuclei in human Duchenne muscular dystrophy. Lab. Inv. 78:1998;1005-1016.
78. Baghdiguian S., Martin M., Richard I., Pons F., Astier C., Bourg N., Hai T.H., Chemaly R., Halaby G., Loiselet J., Anderson L.V.B., Lopez de Munain A., Fardeau M., Mangeat P., Beckmann J.S., Lefranc G. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A. Nature Med. 5:1999;503-511.
79. Olive M., Martnez-Matos J.A., Montero J., Ferrer I. Apoptosis is not the mechanism of cell death of muscle fibers in human muscular dystrophies and inflammatory myopathies. Muscle & Nerve. 20:1997;1328-1330.
80. Tews D.S., Goebel H.H. Cell Death and oxidative damage in inflammatory myopathies. Clin. Immunol. Immunop. 87:1998;240-247.
81. Sugiura T., Murakawa Y., Nagai A., Kondo M., Kobayashi S. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies. Arthritis Rheum. 42:1999;291-298.
82. Tews D.S., Goebel H.H., Meinck H.M. DNA-fragmentation and apoptosis-related proteins of muscle cells in motor neuron disorders. Acta Neurol. Scand. 96:1997;380-386.
83. Roy N., Mahadevan M.S., McLean M., Shttler G., Yaragi Z., Farahani R., Baird S., Besner Johnston A., Lefebvre C., Kang X.L., Salin M., Aubry H., Tamai K., Guan X.P., Ioannou P., Crawford T.O., DeJong P.J., Surh L., Ikeda J.E., Korneluk R.G., MacKenzie A. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80:1995;167-178.
84. Fidzianska A., Goebel H.H., Warlo I. Acute infantile spinal muscular atrophy muscle apoptosis as a proposed pathogenetic mechanism. Brain. 113:1990;433-445.
85. Tews D.S., Goebel H.H. DNA-fragmentation and bcl-2 expression in infantile spinal muscular atrophy. Neuromusc. Disord. 6:1996;265-273.
86. Tews D.S., Goebel H.H. Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J. Neuropath. Exp. Neurol. 56:1997;150-156.
87. Luft R., Ikkos D., Palmieri G., Ernster L., Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical and morphological study. J. Clin. Inv. 41:1962;1776-1804.
88. Wallace D.C., Richter C., Bohr V.A., Cortopassi G., Kadenbach B., Linn S., Linnane A.W., Shay J.W. The role of bioenergetics and mitochondrial DNA mutations in aging and age-related diseases. Dahlem Konferenz. Molecular Aspects of Aging. 1995;199-225 Wiley, Chichester.
89. Monici M.C., Toscano A., Girlanda P., Aguennouz M., Musumeci O., Vita G. Apoptosis in metabolic myopathies. Neuroreport. 9:1998;2431-2435.
90. DiMauro S., Bonilla E., Davidson M., Hirano M., Schon E.A. Mitochondria in neuromuscular disorders. Biochim. Biophys. Acta. 1366:1998;199-210.
91. Servidei S., Mirabella M., Spinazzola A., Di Giovanni S., Silvestri G., Crociani P., DiMauro S., Tonali P. Coenzyme Q10 (CoQ10) reverses clinical and biochemical impairment and prevents apoptosis in familial muscle CoQ10 deficiency. Neuromusc. Disord. 8:1998;268.
92. Vita G., Monici M.C., Toscano A., Musumeci O., Aguennouz M., Migliorato A. DNA fragmentation in metabolic myopathies. Neuromusc. Disord. 8:1998;257.
93. Koga M., Hiromatsu Y., Jimi A., Inoue Y., Nonaka K. Possible involvement of Fas-mediated apoptosis in eye muscle tissue from patients with thyroid-associated ophthalmopathy. Thyroid. 8:1998;311-318.
94. Adams V., Jiang H., Yu J., Mobius-Winkler S., Fiehn E., Linke A., Weigl C., Schuler G., Hambrecht R. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J. Am. Coll. Cardiol. 33:1999;959-965.
95. L. Dalla Libera, R. Zennaro, M. Sandri, G.B. Ambrosio, G. Vescovo, Apotosis and atrophy in rat slow skeletal muscles in chronic heart failure, Am. J. Physiol. (Cell Physiol.), in press.